Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lisata Therapeutics (LSTA) Gross Profit (2016 - 2017)

Historic Gross Profit for Lisata Therapeutics (LSTA) over the last 8 years, with Q1 2017 value amounting to -$119600.0.

  • Lisata Therapeutics' Gross Profit fell 10948.3% to -$119600.0 in Q1 2017 from the same period last year, while for Mar 2017 it was $2.8 million, marking a year-over-year increase of 17347.1%. This contributed to the annual value of $4.1 million for FY2016, which is 7810.98% up from last year.
  • Per Lisata Therapeutics' latest filing, its Gross Profit stood at -$119600.0 for Q1 2017, which was down 10948.3% from $931390.0 recorded in Q4 2016.
  • Over the past 5 years, Lisata Therapeutics' Gross Profit peaked at $1.3 million during Q1 2016, and registered a low of -$6.2 million during Q4 2015.
  • Moreover, its 5-year median value for Gross Profit was $124382.0 (2013), whereas its average is -$890278.1.
  • Its Gross Profit has fluctuated over the past 5 years, first plummeted by 305289.19% in 2014, then soared by 173210.79% in 2016.
  • Quarter analysis of 5 years shows Lisata Therapeutics' Gross Profit stood at $734049.0 in 2013, then crashed by 666.45% to -$4.2 million in 2014, then tumbled by 48.51% to -$6.2 million in 2015, then surged by 115.08% to $931390.0 in 2016, then crashed by 112.84% to -$119600.0 in 2017.
  • Its last three reported values are -$119600.0 in Q1 2017, $931390.0 for Q4 2016, and $706265.0 during Q3 2016.